Human Pooled Primary Hepatocytes (HP2 Heps) provide an ideal culture model for drug testing and drug development. HP2 10 Human Pooled Primary Hepatocytes contain cryopreserved hepatocytes pooled from 10 different donors and have undergone only one freeze cycle. Pooled hepatocytes provide the genetic diversity necessary for superior reliability and predictability of the metabolic characteristics of a test compound relative to a representative population. Pooled hepatocytes increase experimental control and reduce costs by eliminating the need to conduct redundant experiments necessary to obtain population-based data. Each lot has undergone a single freeze cycle, assuring maximum hepatocyte viability and consistency from donor to donor within the pool.
Cell Features:
Each donor’s hepatocytes have been cryopreserved ONCE immediately after isolation and purification.
Pools of 10 or 20 donors are available. Each donor is represented by a statistically significant number of cells relative to the pool.
There is extensive quality control providing characterization of viability and enzyme activity from both individual donors and the total pool.
AcceGen guarantees performance and quality.
Donor information is available.
